IFG Advisory’s Alzamend Neuro ALZN Stock Holding History
Bought
Maintained
Sold
Other funds holding ALZN
IFG Advisory's ALZN Position: Q3 2026 in Review
IFG Advisory held its Alzamend Neuro (ALZN) position steady in Q3 2026 at 22 shares worth $38. The position accounts for ﹤0.01% of the portfolio, ranked #2277.
IFG Advisory first reported a position in ALZN in Q2 2026 and has held it in 2 quarters since. 15 funds tracked by Wall St. Rank hold ALZN as of Q3 2026.
- IFG Advisory held 22 shares of Alzamend Neuro worth $38 as of Q3 2026.
- IFG Advisory left its Alzamend Neuro share count unchanged in Q3 2026.
- Alzamend Neuro made up ﹤0.01% of IFG Advisory's portfolio in Q3 2026, its #2277 holding.
- IFG Advisory first reported a position in Alzamend Neuro in Q2 2026 and has held it in 2 quarters since.
- 15 funds tracked by Wall St. Rank held Alzamend Neuro as of Q3 2026.
Based on IFG Advisory's 13F filing for Q3 2026, filed 9 Nov 2026.